A study in Japan found that low-dose chest CT screening may result in lower lung cancer mortality years after the screening introduction.
Low-dose chest CT screening may result in lower lung cancer mortality in the community four to eight years after the screening introduction, according to findings of a Japanese study in the journal Lung Cancer.
Researchers undertook a 14-year analysis of lung cancer mortality among residents of Hitachi City, Japan, where nearly 40 percent of the inhabitants, aged 50 to 69, were estimated to have participated in at least one screening test between 1998 and 2009. The cancer mortality data were obtained from a regional cancer registry and the standardized mortality ratio (SMR) of lung cancer was calculated for each five-year period between 1995 and 2009 (1995 to 1999, 2000 to 2004, and 2005 to 2009.
The results showed that age-specific lung cancer mortality rates in the community among both men and women, between ages 50 and 79, were lower in 2004 to 2009 than in earlier years - after the implementation of a lung CT screening program.
When the screening program was introduced and during the early years, SMR was about the same, with mortality rates comparable to the national level. But after 2005, the lung cancer mortality rate fell by 24 percent.
“[The] results suggest that wide implementation of low-dose chest CT screening may decrease lung cancer mortality in the community four to eight years after introduction of the screening,” the authors concluded.
U.S. studies, including that of the National Cancer Institute published last year, have shown screening with CT can reduce the risk of dying from lung cancer. Community-based screening programs are gaining traction.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.